Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
This study is enrolling participants by invitation only.
Study NCT00504400.   Last updated on February 17, 2009.
Information provided by University Hospital, Bonn
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Telangiectasis
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Intravitreal injection ranibizumab
Sponsors listed in this trial
University Hospital, Bonn
Novartis


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services